ProQR Therapeutics N.V. buy StockNews.com
Start price
11.11.23
/
50%
€1.25
Target price
11.11.24
-
Performance (%)
189.12%
End price
12.11.24
€3.61
Summary
This prediction ended on 12.11.24 with a price of €3.61. With a performance of 189.12% the BUY prediction by StockNews_com was a big success. StockNews_com has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| ProQR Therapeutics N.V. | 1.790% | 1.790% | -29.367% |
| iShares Core DAX® | 0.224% | 2.031% | 21.399% |
| iShares Nasdaq 100 | 0.371% | -0.955% | 5.637% |
| iShares Nikkei 225® | 0.972% | -0.953% | 13.432% |
| iShares S&P 500 | 0.417% | -0.622% | 3.310% |
Comments by StockNews_com for this prediction
In the thread ProQR Therapeutics N.V. diskutieren
ProQR Therapeutics (NASDAQ: PRQR) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.
Ratings data for PRQR provided by MarketBeat
In the thread Trading ProQR Therapeutics N.V.
Die von StockNews_com gewählte maximale Laufzeit wurde überschritten
Stopped prediction by StockNews_com for ProQR Therapeutics N.V.
ProQR Therapeutics N.V.
Start price
Target price
Perf. (%)
€3.61
29.11.24
29.11.24
-
29.11.25
29.11.25
-45.73%
30.11.25
30.11.25
ProQR Therapeutics N.V.
Start price
Target price
Perf. (%)
€1.81
11.05.24
11.05.24
-
11.05.25
11.05.25
-17.67%
12.05.25
12.05.25
ProQR Therapeutics N.V.
Start price
Target price
Perf. (%)
€1.81
12.03.24
12.03.24
-
12.03.25
12.03.25
-10.87%
13.03.25
13.03.25